您的位置: 首页 > 农业专利 > 详情页

GENE UBE3A MODIFIE POUR UNE APPROCHE DE THERAPIE GENIQUE DU SYNDROME D'ANGELMAN
专利权人:
UNIVERSITY OF SOUTH FLORIDA
发明人:
NASH, KEVIN RON,WEEBER, EDWIN JOHN,DAILY, JENNIFER LEIGH
申请号:
CA2984629
公开号:
CA2984629A1
申请日:
2016.05.09
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
Angelman Syndrome (AS) is a genetic disorder occurring in one in every 15,000 births. It is characterized by severe mental retardation, seizures, difficulty speaking and ataxia. The gene responsible for AS was discovered to be UBE3A and encodes for E6-AP, an ubiquitin ligase. A unique feature of this gene is that it undergoes maternal imprinting in a neuron-specific manner. In the majority of AS cases, there is a mutation or deletion in the maternally inherited UBE3A gene, although other cases are the result of uniparental disomy or mismethylation of the maternal gene. While most human disorders characterized by severe mental retardation involve abnormalities in brain structure, no gross anatomical changes are associated with AS. We have generated a Ube3a protein with additional sequences that should allow the secretion from cells and uptake by neighboring neuronal cells. This would confer a functional E6-AP protein into the neurons and rescue disease pathology.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充